What this is
Single filing record
This page shows the rows from one Form 4 filing as reported to the SEC.
Big buy
Antal Rohit Desai: large open-market buy of PRCT
$2.5M open-market purchase by Antal Rohit Desai, Director at Procept BioRobotics Corp, filed March 9, 2026. Learn more
Feed status Last SEC check:Loading Last Filing: Loading
View PRCT
Access Free feed
Quick read What does this view show?
Why it matters
Read the SEC filing
The original SEC document is the source record. Always verify before drawing conclusions.
How to read it
Role, size, timing
Insider activity carries more weight from senior officers, large dollar values, and clustered timing.
Stacked feeds
Key insider views at a glance
Big BuyPRCT
$29.09+1.08% today
Antal Rohit Desai · Director at Procept BioRobotics Corp
$2.5M
Antal Rohit Desai bought $2.5M of PRCT (Procept BioRobotics Corp).
Insider purchase
Transaction details
Antal Rohit Desai, a Director, reported a $2.5M open-market purchase equal to 0.17% of PRCT's market cap.
Antal Rohit Desai (Director) bought 106,554 shares of PRCT, Procept BioRobotics Corp, Healthcare ($1.43B market cap), at $23.3282 per share on March 6, 2026 for a total of $2.5M (0.17% of the market cap).
Antal Rohit Desai
Director
Purchase value$2.5M
Shares purchased106,554
Price per share$23.3282 per share
- % of market cap
- 0.17%
- Trade date
- March 6, 2026
- Filed
- March 9, 2026
- Filing delay
- 3 days
Permalink https://bluecollarpicks.com/insider-trading/PRCT/buy/80211
Market context
PRCT market snapshot
Current price$29.09
1-day change+1.08%
Market cap$1.43B
SectorHealthcare
Next earningsAugust 4, 2026
$29.09
Current price$29.09
Analyst target$30.44 (+20.9%)
Last enriched June 11, 2026 at 7:38 AM EDT.
Filings
Recent insider trades
Status Loading
Latest visible filing loading.
Public Form 4 filings, normalized for cleaner scanning. What do these codes mean?
| Ticker | Type & Role | Value | |
|---|---|---|---|
Sell Officer | $8.1K | ||
Sell Officer | $61K | ||
Sell Officer | $78.3K | ||
Sell Officer | $8.6K | ||
Sell CFO | $19.9K | ||
Sell Officer | $3.9K | ||
Sell Officer | $79.3K | ||
Buy Director | $33K | ||
Big Buy Director | $1M | ||
Big Buy Director | $1.3M | ||
Big Buy Director | $1.3M | ||
| This filing | Big Buy Director | $2.5M | |
Big Buy Director | $653.5K | ||
Big Buy Director | $3.6M | ||
Grant CEO | $0 | ||
Grant CEO | $0 | ||
Sell Officer | $163.4K | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Sell CFO | $159.3K | ||
Grant CFO | $0 | ||
Grant CFO | $0 | ||
Grant Director | $0 | ||
Grant Director | $0 | ||
Grant Officer | $0 | ||
Grant CFO | $0 | ||
Big Buy Director | $785.1K | ||
Sell Director | $1.2M | ||
Sell Officer | $783.4K | ||
Sell Director | $595.1K | ||
Sell CEO | $312.4K | ||
Sell CFO | $41.8K | ||
Sell Officer | $14.1K | ||
Sell Officer | $18K | ||
Sell Officer | $223.2K | ||
Sell Officer | $220K | ||
Sell CFO | $224.5K | ||
Sell CEO | $975.8K | ||
$8.1K
Sell Officer
$61K
Sell Officer
$78.3K
Sell Officer
$8.6K
Sell Officer
$19.9K
Sell CFO
$3.9K
Sell Officer
$79.3K
Sell Officer
$33K
Buy Director
Big Buy Director
$1.3M
Big Buy Director
$1.3M
Big Buy Director
$2.5M
Big Buy Director
$653.5K
Big Buy Director
$3.6M
Big Buy Director
$0
Grant CEO
$0
Grant CEO
$163.4K
Sell Officer
$0
Grant Officer
$0
Grant Officer
$159.3K
Sell CFO
$0
Grant CFO
$0
Grant CFO
$0
Grant Director
$0
Grant Director
$0
Grant Officer
$0
Grant CFO
$785.1K
Big Buy Director
$1.2M
Sell Director
$783.4K
Sell Officer
$595.1K
Sell Director
$312.4K
Sell CEO
$41.8K
Sell CFO
$14.1K
Sell Officer
$18K
Sell Officer
$223.2K
Sell Officer
$220K
Sell Officer
$224.5K
Sell CFO
$975.8K
Sell CEO
Cluster detail
Cluster members
Ticker context
Ticker summary
Recent insider activity for this company.
Insider detail
Insider activity
Recent transactions grouped by reporting owner.
Filters
Filters
Weekly recap
Get the easier version in your inbox.
Start with the free weekly recap. Upgrade later if you want the paid daily brief.
Free weekly recap. No login required. Unsubscribe any time.
Method Public Form 4 filings, normalized for cleaner scanning. Filtered rows stay available in All Form 4 Filings and ticker history. Which view should I use? →
Paid research tools
CSV exports are becoming a paid feature.
Join the waitlist for founding-member access to CSV exports, saved screens, and premium download tools when they open.